APPLY NOW 2025
  • M. Pharm
  • Ph.D.

Areas of specialization: Pharmaceutics
Academic: 15 years

Interest areas:

  • Pharmacokinetic and toxicokinetic studies
  • Drug/chemical-induced toxicity studies
  • Network Pharmacology & Molecular Docking
  • Drug-drug/herb Interaction studies

 

Awards:

Received Best Researcher Award for the academic year 2017-18 from KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, A.P., India.

 

Projects:

Inhibition of CYP2E1 by rosmarinic acid and ferulic acid to prevent/reduce the toxicity and enhance the efficacy of acetaminophen in rats with osteoarthritis and rheumatoid arthritis (University Seed Grant Sectioned).

 

Book Chapters Published:

Thangaraj Devadoss and Ravindra Babu Pingili. Drugs Under Clinical Trials for the Treatment of Migraine in the book Management of Migraine Pain Emerging Opportunities and Challenges © 2024 Springer Nature Publishing.

 

Number of Publications: 53

 

Recent Publications:

  1. Piyush Mahajan, Mahesh Palkar, Ravindra Babu Pingili. Drug reactive metabolite-induced hepatotoxicity: A Comprehensive review. Toxicology Mechanisms and Methods 2024; 34 (6): 607-627.
  2. Ravindra Babu Pingili, Naveen Babu Kilaru, Siva Reddy Challa, Vara Prasad Saka, Tanvija Kodali, Vyshnavi Toleti and Sirisha Koppula. Hepatoprotective activity of herbal extracts and other compounds against acetaminophen-induced hepatotoxicity by various mechanisms: A narrative review. Annals of Phytomedicine 2023; 12 (2): 70-88.
  3. Ravindra Babu Pingili, Sridhar Vemulapalli, Uday Bhaskar Narra, Sree Varsha Potluri, Naveen Babu Kilaru. Diosmin attenuates paracetamol-induced hepato-and nephrotoxicity via inhibition of CY2E1-mediated metabolism in rats. Journal of Applied Pharmaceutical Science 2023; 13 (12): 96-104.
  4. Ravindra Babu Pingili, Surya Sandeep Mullapudi, Sridhar Vemulapalli, Naveen Babu Kilaru. Influence of hesperetin on the pharmacokinetics of Diltiazem in rats. Journal of Applied Pharmaceutical Science 2023; 13 (6): 093-099.
  5. Ravindra Babu Pingili, Sridhar Vemulapalli, Manideep V. V. N. Gadamsetty, Divya Presingu, Ruthvik Katuri, Vijayalakshmi Rachamsetty & Naveen Babu Kilaru. Chlorzoxazone reduced the paracetamol-induced toxicity via competitive inhibition of CYP2E1-mediated metabolism. Future Journal of Pharmaceutical Sciences 2023; 9: 34.
  6. Ravindra Babu Pingili, Sridhar Vemulapalli, Surya Sandeep Mullapudi, Vijaya R Dirisala, Harsha Sai Chanumolu, Naveen Babu Kilaru. Effect of hesperetin on the pharmacokinetics of metoprolol succinate in rats. Future Journal of Pharmaceutical Sciences 2023; 9: 5.
  7. Ravindra Babu Pingili, Naveen Babu Kilaru, Sridhar Vemulapalli, Surya Sandeep Mullapudi, Krishna Mohan Chinnala. Effect of herbal bioenhancer (naringenin) on the pharmacokinetics of diltiazem in rats via CYP3A4 and P-glycoprotein inhibition. Annals of Phytomedicine 2022; 11 (2): 654-660.
  8. Ravindra Babu Pingili, Sirisha Koppula, Naveen Babu Kilaru, Vijaya R. Dirisala, Vara Prasad Saka, Tanvija Kodali, Vyshnavi Toleti. Therapeutic potential of quercetin for the prevention of various drug and chemical-induced nephrotoxicity: A review. Annals of Phytomedicine 2022; 11 (2): 42-51.
  9. Mohamed Elbashir Abazer Elmamoon, Kolli Udaya Ratna, Ding Deng Goc Ayuel, Mulagalapalli Rajeswari and Ravindra Babu Pingili. Evaluation of the analgesic activity of quercetin and chrysin in animal models. International Journal of Ayurvedic Medicine 2022; 13 (4): 963-969.
  10. Mohammed Albashir Abazar Elmamoon Ball Elsheep, Udaya Ratna Kolli, Yousif Osman Salih Saeed, Jithendra Chimakurthy and Ravindra Babu Pingili. A Comprehensive Review on Pharmacological Activities of Alkaloids: Evidence from Preclinical Studies. International Journal of Ayurvedic Medicine 2022; 13: 6-14.
  11. Ravindra BP, Tanvija Kodali, Naveen Babu Kilaru, Vijaya R. Dirisala, Siva Reddy Challa, Akhila Kondru, Sirisha Koppula, Sravani Melike, Vyshnavi Toleti and Vara Prasad Saka. Possible Mechanisms of Drugs Used in the Treatment of COVID-19: A Pharmacological Perspective. Journal of Pharmaceutical Research International 2022; 34 (1B): 43-57.
  12. Ravindra BP, Lavanya Nalluri, Madhavi Mannam, Thanvija Kodali and Naveen Babu Kilaru. A Cross-sectional Study on the Development of Diabetic Cardiovascular Complications in Type 2 Diabetes Mellitus in a South Indian Tertiary Care Hospital. Journal of Pharmaceutical Research International 2022; 34 (8A): 19-32.
  13. Ravindra BP, Sridhar Vemulapalli, Vijaya R Dirisala, Surya Sandeep Mullapudi, Yamini Gullapalli, Naveen Babu Kilaru. Xenobiotica 2021; 51: 926-932.

 

Dissertations/Projects Guided: 13

 

Ph. D. : 01 (On going)

 

Professional memberships:

  • Life member, Indian Pharmaceutical Association (AP/GUN/ON/LM/000025).
  • Life Member, Association of Pharmaceutical Teachers of India: MA/LM-3440

 

Other achievements/ Trainings:

  • Member, Criterion-II of NAAC Accreditation Process at Vignan’s Foundation for Science, Technology and Research (Deemed to be University), Guntur, A. P.
  • Member, Criterion-III of NBA Accreditation Process at KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, A.P., India.
  • Member, Board of Academics at Vignan’s Foundation for Science, Technology and Research (Deemed to be University), Guntur, A. P.
  • Counselling Co-ordinator at Vignan’s Foundation for Science, Technology and Research (Deemed to be University), Guntur, A. P.
  • Worked in Training and Placement Cell, Examinations Cell, Faculty Forum Committee and as Editorial Member of College Magazine
  • Delivered talks at three national seminars

 

Official email ID: ravindrababu.pingili@nmims.edu

 

Official Phone No.: 02563 – 295545 (Extn. 103)